91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Small Molecule CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Small Molecule CDMO - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID: 
PB511244026
Publication Date: 
November 15, 2024
Pages: 
150
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 3,950.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

The global market for Small Molecule CDMO was estimated to be worth US$ 1162 million in 2023 and is forecast to a readjusted size of US$ 2417.3 million by 2030 with a CAGR of 11.5% during the forecast period 2024-2030
North American market for Small Molecule CDMO was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule CDMO was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Small Molecule CDMO was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Small Molecule CDMO include Lonza, Catalent, Thermo Fisher, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Small Molecule CDMO, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Small Molecule CDMO by region & country, by Type, and by Application.
The Small Molecule CDMO market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule CDMO.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical
Segment by Type:
Development
API Production
Segment by Application
Pharmaceutical
Biotechnology
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Small Molecule CDMO manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Small Molecule CDMO in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Small Molecule CDMO in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Market Overview
1.1 Small Molecule CDMO Product Introduction
1.2 Global Small Molecule CDMO Market Size Forecast
1.3 Small Molecule CDMO Market Trends & Drivers
1.3.1 Small Molecule CDMO Industry Trends
1.3.2 Small Molecule CDMO Market Drivers & Opportunity
1.3.3 Small Molecule CDMO Market Challenges
1.3.4 Small Molecule CDMO Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Small Molecule CDMO Players Revenue Ranking (2023)
2.2 Global Small Molecule CDMO Revenue by Company (2019-2024)
2.3 Key Companies Small Molecule CDMO Manufacturing Base Distribution and Headquarters
2.4 Key Companies Small Molecule CDMO Product Offered
2.5 Key Companies Time to Begin Mass Production of Small Molecule CDMO
2.6 Small Molecule CDMO Market Competitive Analysis
2.6.1 Small Molecule CDMO Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Small Molecule CDMO Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CDMO as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Development
3.1.2 API Production
3.2 Global Small Molecule CDMO Sales Value by Type
3.2.1 Global Small Molecule CDMO Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Small Molecule CDMO Sales Value, by Type (2019-2030)
3.2.3 Global Small Molecule CDMO Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Biotechnology
4.2 Global Small Molecule CDMO Sales Value by Application
4.2.1 Global Small Molecule CDMO Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Small Molecule CDMO Sales Value, by Application (2019-2030)
4.2.3 Global Small Molecule CDMO Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Small Molecule CDMO Sales Value by Region
5.1.1 Global Small Molecule CDMO Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Small Molecule CDMO Sales Value by Region (2019-2024)
5.1.3 Global Small Molecule CDMO Sales Value by Region (2025-2030)
5.1.4 Global Small Molecule CDMO Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Small Molecule CDMO Sales Value, 2019-2030
5.2.2 North America Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Small Molecule CDMO Sales Value, 2019-2030
5.3.2 Europe Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Small Molecule CDMO Sales Value, 2019-2030
5.4.2 Asia Pacific Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Small Molecule CDMO Sales Value, 2019-2030
5.5.2 South America Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Small Molecule CDMO Sales Value, 2019-2030
5.6.2 Middle East & Africa Small Molecule CDMO Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Small Molecule CDMO Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Small Molecule CDMO Sales Value
6.3 United States
6.3.1 United States Small Molecule CDMO Sales Value, 2019-2030
6.3.2 United States Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Small Molecule CDMO Sales Value, 2019-2030
6.4.2 Europe Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Small Molecule CDMO Sales Value, 2019-2030
6.5.2 China Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.5.3 China Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Small Molecule CDMO Sales Value, 2019-2030
6.6.2 Japan Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Small Molecule CDMO Sales Value, 2019-2030
6.7.2 South Korea Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Small Molecule CDMO Sales Value, 2019-2030
6.8.2 Southeast Asia Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Small Molecule CDMO Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Small Molecule CDMO Sales Value, 2019-2030
6.9.2 India Small Molecule CDMO Sales Value by Type (%), 2023 VS 2030
6.9.3 India Small Molecule CDMO Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Profile
7.1.2 Lonza Main Business
7.1.3 Lonza Small Molecule CDMO Products, Services and Solutions
7.1.4 Lonza Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.1.5 Lonza Recent Developments
7.2 Catalent
7.2.1 Catalent Profile
7.2.2 Catalent Main Business
7.2.3 Catalent Small Molecule CDMO Products, Services and Solutions
7.2.4 Catalent Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.2.5 Catalent Recent Developments
7.3 Thermo Fisher
7.3.1 Thermo Fisher Profile
7.3.2 Thermo Fisher Main Business
7.3.3 Thermo Fisher Small Molecule CDMO Products, Services and Solutions
7.3.4 Thermo Fisher Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.3.5 Wuxi Apptec Recent Developments
7.4 Wuxi Apptec
7.4.1 Wuxi Apptec Profile
7.4.2 Wuxi Apptec Main Business
7.4.3 Wuxi Apptec Small Molecule CDMO Products, Services and Solutions
7.4.4 Wuxi Apptec Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.4.5 Wuxi Apptec Recent Developments
7.5 PharmaBlock
7.5.1 PharmaBlock Profile
7.5.2 PharmaBlock Main Business
7.5.3 PharmaBlock Small Molecule CDMO Products, Services and Solutions
7.5.4 PharmaBlock Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.5.5 PharmaBlock Recent Developments
7.6 Asym Chemical
7.6.1 Asym Chemical Profile
7.6.2 Asym Chemical Main Business
7.6.3 Asym Chemical Small Molecule CDMO Products, Services and Solutions
7.6.4 Asym Chemical Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.6.5 Asym Chemical Recent Developments
7.7 Jiuzhou Pharmaceutical
7.7.1 Jiuzhou Pharmaceutical Profile
7.7.2 Jiuzhou Pharmaceutical Main Business
7.7.3 Jiuzhou Pharmaceutical Small Molecule CDMO Products, Services and Solutions
7.7.4 Jiuzhou Pharmaceutical Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.7.5 Jiuzhou Pharmaceutical Recent Developments
7.8 Pharmaron Beijing
7.8.1 Pharmaron Beijing Profile
7.8.2 Pharmaron Beijing Main Business
7.8.3 Pharmaron Beijing Small Molecule CDMO Products, Services and Solutions
7.8.4 Pharmaron Beijing Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.8.5 Pharmaron Beijing Recent Developments
7.9 Porton Pharma
7.9.1 Porton Pharma Profile
7.9.2 Porton Pharma Main Business
7.9.3 Porton Pharma Small Molecule CDMO Products, Services and Solutions
7.9.4 Porton Pharma Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.9.5 Porton Pharma Recent Developments
7.10 ChemPartner
7.10.1 ChemPartner Profile
7.10.2 ChemPartner Main Business
7.10.3 ChemPartner Small Molecule CDMO Products, Services and Solutions
7.10.4 ChemPartner Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.10.5 ChemPartner Recent Developments
7.11 Jiangsu Sinopep
7.11.1 Jiangsu Sinopep Profile
7.11.2 Jiangsu Sinopep Main Business
7.11.3 Jiangsu Sinopep Small Molecule CDMO Products, Services and Solutions
7.11.4 Jiangsu Sinopep Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.11.5 Jiangsu Sinopep Recent Developments
7.12 DELPHARM
7.12.1 DELPHARM Profile
7.12.2 DELPHARM Main Business
7.12.3 DELPHARM Small Molecule CDMO Products, Services and Solutions
7.12.4 DELPHARM Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.12.5 DELPHARM Recent Developments
7.13 Aenova Group
7.13.1 Aenova Group Profile
7.13.2 Aenova Group Main Business
7.13.3 Aenova Group Small Molecule CDMO Products, Services and Solutions
7.13.4 Aenova Group Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.13.5 Aenova Group Recent Developments
7.14 Siegfried Holding AG
7.14.1 Siegfried Holding AG Profile
7.14.2 Siegfried Holding AG Main Business
7.14.3 Siegfried Holding AG Small Molecule CDMO Products, Services and Solutions
7.14.4 Siegfried Holding AG Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.14.5 Siegfried Holding AG Recent Developments
7.15 Recipharm AB
7.15.1 Recipharm AB Profile
7.15.2 Recipharm AB Main Business
7.15.3 Recipharm AB Small Molecule CDMO Products, Services and Solutions
7.15.4 Recipharm AB Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.15.5 Recipharm AB Recent Developments
7.16 FAREVA SA
7.16.1 FAREVA SA Profile
7.16.2 FAREVA SA Main Business
7.16.3 FAREVA SA Small Molecule CDMO Products, Services and Solutions
7.16.4 FAREVA SA Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.16.5 FAREVA SA Recent Developments
7.17 Almac Group
7.17.1 Almac Group Profile
7.17.2 Almac Group Main Business
7.17.3 Almac Group Small Molecule CDMO Products, Services and Solutions
7.17.4 Almac Group Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.17.5 Almac Group Recent Developments
7.18 Cambrex
7.18.1 Cambrex Profile
7.18.2 Cambrex Main Business
7.18.3 Cambrex Small Molecule CDMO Products, Services and Solutions
7.18.4 Cambrex Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.18.5 Cambrex Recent Developments
7.19 Charles River
7.19.1 Charles River Profile
7.19.2 Charles River Main Business
7.19.3 Charles River Small Molecule CDMO Products, Services and Solutions
7.19.4 Charles River Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.19.5 Charles River Recent Developments
7.20 CORDEN PHARMA
7.20.1 CORDEN PHARMA Profile
7.20.2 CORDEN PHARMA Main Business
7.20.3 CORDEN PHARMA Small Molecule CDMO Products, Services and Solutions
7.20.4 CORDEN PHARMA Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.20.5 CORDEN PHARMA Recent Developments
7.21 Jubilant Pharmova
7.21.1 Jubilant Pharmova Profile
7.21.2 Jubilant Pharmova Main Business
7.21.3 Jubilant Pharmova Small Molecule CDMO Products, Services and Solutions
7.21.4 Jubilant Pharmova Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.21.5 Jubilant Pharmova Recent Developments
7.22 Consort Medical
7.22.1 Consort Medical Profile
7.22.2 Consort Medical Main Business
7.22.3 Consort Medical Small Molecule CDMO Products, Services and Solutions
7.22.4 Consort Medical Small Molecule CDMO Revenue (US$ Million) & (2019-2024)
7.22.5 Consort Medical Recent Developments
8 Industry Chain Analysis
8.1 Small Molecule CDMO Industrial Chain
8.2 Small Molecule CDMO Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Small Molecule CDMO Sales Model
8.5.2 Sales Channel
8.5.3 Small Molecule CDMO Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

Lonza
Catalent
Thermo Fisher
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Jiangsu Sinopep
DELPHARM
Aenova Group
Siegfried Holding AG
Recipharm AB
FAREVA SA
Almac Group
Cambrex
Charles River
CORDEN PHARMA
Jubilant Pharmova
Consort Medical

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/small-molecule-cdmo-global-market-share-and-ranking-overall-sales-and-demand-forecast-2024

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare